MoneyWorks4Me

Vivo Bio Tech - Quaterly Results

12 Aug 2025 Evaluate
The company witnessed a 22.55% growth in the revenue at Rs. 124.19 millions for the quarter ended June 2025 as compared to Rs. 101.34 millions during the year-ago period.The Net Profit of the company vaulted to 670.79% to Rs. 13.72  millions from Rs. 1.78 millions in the previous quarter.Operating profit for the quarter ended June 2025 rose to 56.62 millions as compared to 43.87 millions of corresponding quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 124.19 101.34 22.55 124.19 101.34 22.55 466.72 448.81 3.99
Other Income 1.38 0.12 1050.00 1.38 0.12 1050.00 48.05 0.39 12220.51
PBIDT 56.62 43.87 29.06 56.62 43.87 29.06 256.01 211.23 21.20
Interest 15.03 19.24 -21.88 15.03 19.24 -21.88 75.04 77.78 -3.52
PBDT 41.59 24.63 68.86 41.59 24.63 68.86 180.97 133.45 35.61
Depreciation 26.44 22.29 18.62 26.44 22.29 18.62 90.17 92.91 -2.95
PBT 15.15 2.34 547.44 15.15 2.34 547.44 90.80 40.54 123.98
TAX 1.43 0.56 155.36 1.43 0.56 155.36 15.11 15.32 -1.37
Deferred Tax -6.47 -1.42 355.63 -6.47 -1.42 355.63 -5.72 -1.43 300.00
PAT 13.72 1.78 670.79 13.72 1.78 670.79 75.69 25.22 200.12
Equity 198.94 149.04 33.48 198.94 149.04 33.48 171.65 149.04 15.17
PBIDTM(%) 45.59 43.29 5.32 45.59 43.29 5.32 54.85 47.06 16.55
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..